S.T. Mulder, MSc

S.T. Mulder, MSc
E-mail:
s.t.mulder umcg.nl

Research

Publications
  1. The effects of dapagliflozin on urinary metabolites in patients with type 2 diabetes

    Mulder, S., Heerspink, H. J. L., Darshi, M., Kim, J. J., Laverman, G. D., Sharma, K. & Pena, M. J., 2-Jul-2019, In : Diabetes obesity & metabolism. 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

    Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A. & Mayer, G., Jul-2019, In : Diabetologia. 62, 7, p. 1154-1166 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. An integrative systems biology approach for precision medicine in diabetic kidney disease

    Mulder, S., Hamidi, H., Kretzler, M. & Ju, W., Oct-2018, In : Diabetes obesity & metabolism. 20, p. 6-13 8 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

    Schievink, B., Kropelin, T., Mulder, S., Parving, H. -H., Remuzzi, G., Dwyer, J., Vemer, P., de Zeeuw, D. & Heerspink, H. J. L., Jan-2016, In : Diabetes obesity & metabolism. 18, 1, p. 64-71 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (4) »

View graph of relations

ID: 436880